PCSK9 and atherosclerosis: This enhancement ultimately reduces the formation of atherosclerotic plaques in adeno-associated virus-proprotein convertase subtilisin/kexin type 9 (AAV-PCSK9)-induced atherosclerosis in ACE10/10 mice (7, 8).